Compugen
CGEN
#8898
Rank
โ‚น12.77 B
Marketcap
โ‚น135.74
Share price
-6.21%
Change (1 day)
1.45%
Change (1 year)

Compugen (CGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น4.85 Billion

According to Compugen's latest financial reports the company's total liabilities are โ‚น4.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Compugen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น5.15 B11%
2023-12-31โ‚น4.64 B240.15%
2022-12-31โ‚น1.36 B-27.99%
2021-12-31โ‚น1.89 B39.86%
2020-12-31โ‚น1.35 B23.09%
2019-12-31โ‚น1.10 B-1.18%
2018-12-31โ‚น1.11 B84.7%
2017-12-31โ‚น0.60 B16.51%
2016-12-31โ‚น0.51 B-17.19%
2015-12-31โ‚น0.62 B11.24%
2014-12-31โ‚น0.56 B-63.34%
2013-12-31โ‚น1.53 B149.25%
2012-12-31โ‚น0.61 B22.43%
2011-12-31โ‚น0.50 B37.22%
2010-12-31โ‚น0.36 B183.21%
2009-12-31โ‚น0.12 B-36.56%
2008-12-31โ‚น0.20 B18.56%
2007-12-31โ‚น0.17 B-24.15%
2006-12-31โ‚น0.22 B-14.01%
2005-12-31โ‚น0.26 B5.18%
2004-12-31โ‚น0.25 B-28.68%
2003-12-31โ‚น0.35 B-12.51%
2002-12-31โ‚น0.40 B15.19%
2001-12-31โ‚น0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Seagen
SGEN
โ‚น97.43 B 1,906.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.23 B-95.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.930 T 60,252.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Genetic Technologies
GENE
โ‚น0.26 B-94.60%๐Ÿ‡ฆ๐Ÿ‡บ Australia